Clinical Trials Register

Trials with a EudraCT protocol (56)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

56 result(s) found for: Burkitt's lymphoma. Displaying page 1 of 3.

EudraCT Number: 2011-003487-75

Sponsor Protocol Number: CARMEN

Start Date*: 2011-10-03

Sponsor Name:FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR

Full Title: Phase II trial on safety and activity of intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt's lymphoma.

Medical condition: Burkitt's lymphoma in HIV-positive patients.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006595	Burkitt's lymphoma	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-006154-97

Sponsor Protocol Number: 148/2006/U/Sper

Start Date*: 2007-01-09

Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Full Title: HEMOS ALL 0105 Intensification therapy of mature B-ALL, Burkitt and Burkitt like and other HIgh Grade Non-Hodgkinﾒs Lymphoma in Adults

Medical condition: B-ALL, Burkitt and Burkitt like and Non-Hodgkinﾒs Lymphoma in Adults

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10006595	Burkitt's lymphoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2012-003141-16

Sponsor Protocol Number: HEM2012BL01

Start Date*: 2012-10-18

Sponsor Name:VU University Medical Center

Full Title: Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial.

Medical condition: Burkitt lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10005329 - Blood and lymphatic system disorders	10006596	Burkitt's lymphomas	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-004555-16

Sponsor Protocol Number: M20-429

Start Date*: 2022-04-25

Sponsor Name:AbbVie Deutschland GmbH & Co. KG

Full Title: A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients with Relapsed/ Refractory Aggressive Mature B-cell Neoplasms

Medical condition: Relapsed/refractory Burkitt's or Burkitt-like lymphoma/leukemia, Diffuse large B-cell lymphoma , or other aggressive mature (CD20+) B-cell lymphomas

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004851	10006596	Burkitt's lymphomas	HLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003903	B-cell lymphoma refractory	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012822	Diffuse large B-cell lymphoma refractory	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Ongoing) DE (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) BE (Trial now transitioned) CZ (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2014-002654-39

Sponsor Protocol Number: HO130

Start Date*: 2015-02-25

Sponsor Name:HOVON Foundation

Full Title: A phase II study evaluating the effect of the addition of lenalidomide to R-CHOP for patients with newly diagnosed MYC positive DLBCL and BCL-U

Medical condition: MYC positive diffuse large B cell lymphoma and Burkitt lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004943	10012819	Diffuse large B-cell lymphomas	HLT
	20.0	100000004943	10006596	Burkitt's lymphomas	HLT

Population Age: Adults

Gender: Male, Female

Trial protocol: NL (Ongoing) BE (Completed)

Trial results: View results

EudraCT Number: 2013-004394-27

Sponsor Protocol Number: HO127

Start Date*: 2014-06-23

Sponsor Name:HOVON Foundation

Full Title: Phase III study comparing R-CODOX-M/R-IVAC versus dose-adjusted EPOCH-R (DA-EPOCH-R) for patients with newly diagnosed high risk Burkitt lymphoma

Medical condition: High risk Burkitt Lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000013123	10006605	Burkitt's tumor or lymphoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Trial now transitioned) NL (Trial now transitioned) GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2005-003479-19

Sponsor Protocol Number: UCL/05/134

Start Date*: 2006-02-02

Sponsor Name:University College London

Full Title: A Phase II Single Arm Study of the use of CODOX-M/IVAC with Rituximab (R-CODOX-M/IVAC) in the treatment of patients with Diffuse Large B-Cell Lymphoma (DLBCL) or Burkitt's Lymphoma (BL) of Internat...

Medical condition: Diffuse large B-cell lymphoma Burkitt's lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	13.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006595	Burkitt's lymphoma	PT
	13.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012818	Diffuse large B-cell lymphoma	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2008-001833-87

Sponsor Protocol Number: 00600

Start Date*: 2008-06-20

Sponsor Name:University Medical Center Freiburg

Full Title: Use of Palifermin to reduce the duration, frequency and severity of oral mucositis after high dose therapy with BEAM and autologous peripheral blood stem cell transplantation in patients with malig...

Medical condition: malign lymphoma (primary high risks patients: - therapy refractory / relapsed NHL - therapy refractory / relapsed M. Hodgkin - Burkitt-NHL

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10006595	Burkitt's lymphoma	LLT
	9.1		10029609	Non-Hodgkin's lymphoma unspecified histology aggressive recurrent	LLT
	9.1		10029610	Non-Hodgkin's lymphoma unspecified histology aggressive refractory	LLT
	9.1		10020328	Hodgkin's lymphoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2010-019224-31

Sponsor Protocol Number: IGR2009/1593

Start Date*: 2012-06-06

Sponsor Name:Institut Gustave Roussy

Full Title: INTERGROUP TRIAL FOR CHILDREN OR ADOLESCENTS WITH B-CELL NHL OR B-AL: EVALUATION OF RITUXIMAB EFFICACY AND SAFETY IN HIGH RISK PATIENTS

Medical condition: untreated advanced stage B-cell NHL or B-AL.

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067070	Follicular B-cell non-Hodgkin's lymphoma	LLT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006595	Burkitt's lymphoma	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067194	Burkitt's leukemia	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: BE (Completed) GB (GB - no longer in EU/EEA) FR (Completed) ES (Temporarily Halted) NL (Completed) HU (Completed) IT (Completed) PL (Completed)

Trial results: (No results available)

EudraCT Number: 2015-001697-17

Sponsor Protocol Number: R1979-ONC-1504

Start Date*: 2015-12-01

Sponsor Name:Regeneron Pharmaceuticals, Inc

Full Title: A Phase 1 Study to Assess Safety and Tolerability of REGN1979, an anti-CD20 x anti- CD3 bispecific monoclonal antibody, and REGN2810, an anti-programmed death-1 monoclonal antibody, in Patients wit...

Medical condition: B-cell malignancies

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003903	B-cell lymphoma refractory	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003917	B-cell type acute leukaemia	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026945	Mature B-cell type acute leukaemia	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067184	Burkitt's leukaemia	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003890	B precursor type acute leukaemia	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10020267	Hodgkin's disease refractory	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10020266	Hodgkin's disease recurrent	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003902	B-cell lymphoma recurrent	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Restarted)

Trial results: (No results available)

EudraCT Number: 2013-004526-28

Sponsor Protocol Number: BMT-CTN#1101

Start Date*: 2015-06-17

Sponsor Name:National Institutes of Health/National Heart, Lung and Bood Institute

Full Title: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity(RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow ...

Medical condition: patients eligible for a hematopoietic stem cell transplantation with a diagnosis of: 1)Acute lymphoblastic leukemia/lymphoma, acute myelogenous leukemia, or Burkitt’s lymphoma in remission. 2)Lym...

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.1	10005329 - Blood and lymphatic system disorders	10025319	Lymphomas Hodgkin's disease	HLGT
	16.1	100000004864	10024330	Leukemia acute	LLT
	16.1	10005329 - Blood and lymphatic system disorders	10025320	Lymphomas non-Hodgkin's B-cell	HLGT
	16.1	10005329 - Blood and lymphatic system disorders	10025321	Lymphomas non-Hodgkin's T-cell	HLGT
	16.1	10005329 - Blood and lymphatic system disorders	10006596	Burkitt's lymphomas	HLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2021-003993-30

Sponsor Protocol Number: IDP-121-1

Start Date*: 2022-07-01

Sponsor Name:IDP Discovery Pharma S.L.

Full Title: A phase 1/2 multicenter, open-label, dose-escalation study of IDP-121 in patients with relapsed/refractory hematologic malignancies

Medical condition: Chronic lymphocytic leukemia (CLL) Diffuse large B cell lymphoma not otherwise specified (DLBCL-NOS) High-grade B cell lymphoma with double or triple hit rearrangement (HGBL-DH/TH) High-grade B cel...

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004864	10008976	Chronic lymphocytic leukemia	LLT
	21.0	100000004864	10028228	Multiple myeloma	LLT
	20.0	100000004851	10020068	High grade B-cell lymphomas Burkitt-like lymphoma	HLT
	21.0	100000004864	10012820	Diffuse large B-cell lymphoma NOS	LLT
	21.1	100000004864	10020069	High grade B-cell lymphoma Burkitt-like lymphoma NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-001067-64	Sponsor Protocol Number: BURKIMAB007/04	Start Date*: 2005-07-25
Sponsor Name:PETHEMA Foundation
Full Title: Multicentre study of optimization of therapy in mature B-cell acute lymphoblastic leukemia and Burkitt's lymphoma in adults (over 15 years)
Medical condition: Adults B-ALL and Burkitt´s Lymphoma
Disease:
Population Age: Adolescents, Under 18, Adults		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2016-002044-16

Sponsor Protocol Number: 20150292

Start Date*: 2016-10-04

Sponsor Name:Amgen Inc.

Full Title: A Phase 2/3 Multi-center Study of Evaluate the Safety and Efficacy of Blinatumomab in Subjects with Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma

Medical condition: Subjects with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10020067	High grade B-cell lymphoma Burkitt-like lymphoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10036710	Primary mediastinal large B-cell lymphoma	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10063908	Non-Hodgkin's lymphoma unspecified histology aggressive	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012818	Diffuse large B-cell lymphoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) BE (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2021-006556-14

Sponsor Protocol Number: RHCART1A

Start Date*: 2022-07-08

Sponsor Name:Rigshospitalet

Full Title: CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19-positive ALL and NHL (DAN-CART 1901)

Medical condition: Acute Lymphoblastic Leukemia and B-cell Non Hodgkin Lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066109	Precursor B-lymphoblastic leukemia acute	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012855	Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10060669	B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma	LLT
	20.0	100000004851	10036524	Precursor B-lymphoblastic lymphomas	HLT
	20.0	100000004851	10026798	Mantle cell lymphomas	HLT
	20.0	100000004851	10020068	High grade B-cell lymphomas Burkitt-like lymphoma	HLT
	20.0	100000004851	10036711	Primary mediastinal large B-cell lymphomas	HLT
	24.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10085128	Follicular lymphoma	PT

Population Age: Infants and toddlers, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2016-000704-28

Sponsor Protocol Number: GCP#05.01.020

Start Date*: 2016-06-16

Sponsor Name:Gamida Cell Ltd

Full Title: A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, Umbilical Cord Blood-derived, Stem and Progenitor Cells, versus Unmanipulated Umbilical Cord...

Medical condition: High risk haematological malignancies

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.0	100000004864	10000845	Acute lymphoblastic leukemia	LLT
	19.0	100000004864	10000886	Acute myeloid leukemia	LLT
	19.0	100000004864	10009015	Chronic myeloid leukemia	LLT
	19.0	100000004864	10028534	Myelodysplastic syndrome NOS	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Completed) NL (Completed) GB (GB - no longer in EU/EEA) IT (Prematurely Ended) PT (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2020-005843-21

Sponsor Protocol Number: KT-US-982-5968

Start Date*: 2022-02-08

Sponsor Name:KITE PHARMA INC.

Full Title: Long-term Follow-up Study for Participants of Kite Sponsored Interventional Studies Treated With Gene-Modified Cells

Medical condition: B-cell malignancies and Acute Myeloid Leukemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026801	Mantle cell lymphoma refractory	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008977	Chronic lymphocytic leukemia recurrent	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008978	Chronic lymphocytic leukemia refractory	LLT
	23.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10065856	Non-Hodgkin's lymphoma unspecified histology indolent	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012822	Diffuse large B-cell lymphoma refractory	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10060558	Acute myeloid leukemia recurrent	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10081514	Acute myeloid leukemia refractory	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10063621	Acute lymphoblastic leukaemia recurrent	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006599	Burkitt's lymphoma refractory	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10036714	Primary mediastinal large B-cell lymphoma refractory	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Trial now transitioned) FR (Trial now transitioned) DE (Trial now transitioned) NL (Trial now transitioned) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2007-002414-19

Sponsor Protocol Number:

Start Date*: 2008-05-22

Sponsor Name:GOELAMS

Full Title: Etude prospective multicentrique de phase II évaluant la radioimmunothérapie fractionnée avec un anticorps humanisé anti-CD22 marqué à l'yttrium 90 (90Y-DOTA-hLL2) en consolidation après immuno-chi...

Medical condition: lymphomes B agressifs disséminés du sujet de plus de 60 ans et de moins de 80 ans.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10012868	Diffuse large cell lymphoma (High grade B-cell lymphoma Burkitt-like lymphoma) (Working Formulation)	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-005217-38

Sponsor Protocol Number: DSHNHL2004-2

Start Date*: 2008-07-25

Sponsor Name:German High Grade Non-Hodgkins Lymphoma group

Full Title: Randomiseret forsøg der sammenligner 4 og 6 kemoterapicykler med CHOP (Cyklofosfamid, Doxorubicin, Vincristin og Prednison) i 21-dages intervaller, begge med 6 cykler immunterapi med monoklonalt an...

Medical condition: Patients with untreated aggressive CD20+ Non-Hodgkins Lymphoma aged 18 to 60 years without major accompanying disorders with no risk factor according to IPI and no bulky disease (<7,5cm)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10003899	B-cell lymphoma	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DK (Completed) IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-017279-77

Sponsor Protocol Number: LNH2009-1B

Start Date*: 2013-07-02

Sponsor Name:GELARC

Full Title: Randomized Phase III study evaluating the non-inferiority of a treatment adapted to the early response evaluated with 18F-FDG PET compared to a standard treatment, for patients aged from 18 to 80 y...

Medical condition: Patient with Diffuse Large B cells with IPI=0 not previously treated

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10012818	Diffuse large B-cell lymphoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) BE (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Burkitt's lymphoma